NCT04463394View on ClinicalTrials.gov

The Hemodynamic Effects of Vasopressin in Patients With Fontan Physiology

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

February 15, 2022

Study Completion Date

February 15, 2022

Conditions
HypotensionFontan Physiology
Interventions
DRUG

Vasopressin

Vasopressin administered intravenously

Trial Locations (2)

94305

Stanford University Medical Center, Stanford

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT04463394 - The Hemodynamic Effects of Vasopressin in Patients With Fontan Physiology | Biotech Hunter | Biotech Hunter